1. Home
  2. MIST vs OPOF Comparison

MIST vs OPOF Comparison

Compare MIST & OPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • OPOF
  • Stock Information
  • Founded
  • MIST 2003
  • OPOF 1922
  • Country
  • MIST Canada
  • OPOF United States
  • Employees
  • MIST N/A
  • OPOF N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • OPOF Major Banks
  • Sector
  • MIST Health Care
  • OPOF Finance
  • Exchange
  • MIST Nasdaq
  • OPOF Nasdaq
  • Market Cap
  • MIST 81.5M
  • OPOF 99.6M
  • IPO Year
  • MIST N/A
  • OPOF N/A
  • Fundamental
  • Price
  • MIST $1.43
  • OPOF $19.76
  • Analyst Decision
  • MIST Strong Buy
  • OPOF
  • Analyst Count
  • MIST 3
  • OPOF 0
  • Target Price
  • MIST $13.00
  • OPOF N/A
  • AVG Volume (30 Days)
  • MIST 177.8K
  • OPOF 2.5K
  • Earning Date
  • MIST 11-11-2024
  • OPOF 10-24-2024
  • Dividend Yield
  • MIST N/A
  • OPOF 2.74%
  • EPS Growth
  • MIST N/A
  • OPOF N/A
  • EPS
  • MIST N/A
  • OPOF 1.60
  • Revenue
  • MIST N/A
  • OPOF $59,503,000.00
  • Revenue This Year
  • MIST N/A
  • OPOF N/A
  • Revenue Next Year
  • MIST N/A
  • OPOF N/A
  • P/E Ratio
  • MIST N/A
  • OPOF $12.72
  • Revenue Growth
  • MIST N/A
  • OPOF N/A
  • 52 Week Low
  • MIST $1.12
  • OPOF $13.49
  • 52 Week High
  • MIST $3.52
  • OPOF $21.00
  • Technical
  • Relative Strength Index (RSI)
  • MIST 42.50
  • OPOF 69.06
  • Support Level
  • MIST $1.41
  • OPOF $19.20
  • Resistance Level
  • MIST $1.53
  • OPOF $19.65
  • Average True Range (ATR)
  • MIST 0.07
  • OPOF 0.33
  • MACD
  • MIST -0.01
  • OPOF 0.10
  • Stochastic Oscillator
  • MIST 26.96
  • OPOF 69.31

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About OPOF Old Point Financial Corporation

Old Point Financial Corp functions in the financial services domain in the United States. As the holding company of The Bank and Trust, it is a nationally chartered trust and wealth management service, provider. Its suite of services includes commercial banking solutions such as loan, deposit and cash management, which are rendered through a chain of branches throughout the country. It operates through segments such as Bank, Wealth and Company.

Share on Social Networks: